Tuberculosis

Manson's Tropical Diseases, Twenty-second Edition

Volumn , Issue , 2008, Pages 983-1038

  Grange, John M ^a   Zumla, Alimuddin I ^{a,b,c,d,e,f,g,h,i}  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f UNIVERSITY OF ZAMBIA   (Zambia)

^g UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^h The Universities of Zambia   (United Kingdom)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85158960616     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4470-3.50060-4     Document Type: Chapter

References (135)

1. MC Gutierrez, S Brise, R Brosch, et al. (2005) Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS 1(1), e5.
2. S Gagneux, K DeRiemer, Tran Van, et al. (2006) Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci 103 2869-2873.
3. K Kremer, JR Glynn, T Lillebaek, et al. (2004) Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol 42 4040-4049.
4. OS Toungoussova, DA Caugant, P Sandven, et al. (2004) Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunol Med Microbiol 42 281-290.
5. JR Glynn, AC Crampin, MD Yates, et al. (2005) The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in northern Malawi. J Infect Dis 192 480-487.
6. A Wallgren (1948) The time table of tuberculosis. Tubercle 29 245-251.
7. GAW Rook and A Zumla (2001) Advances in the immunopathogenesis of pulmonary tuberculosis. Curr Opin Pulm Med 7 116-123.
8. RJ Wilkinson, M Llewelyn, Z Toossi, et al. (2000) Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 355 618-621.
9. R Hernandez-Pando, M de la Luz Streber, H Orozco, et al. (1998) Emergent immunoregulatory properties of combined glucocorticoid and anti-glucocorticoid steroids in a model of tuberculosis. QJM 91 755-766.
10. A Iwasaki and R Medzhitov (2004) Toll-like receptor control of the adaptive immune response. Nature Immunol 5 987-995.
11. TK Means, BW Jones, AB Schromm, et al. (2001) Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 166 4074-4082.
12. I Smith (2003) Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 16 463-496.
13. V Deretic, S Singh, S Master, et al. (2006) Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell Microbiol 8 719-727.
14. AS Pym, P Brodin, L Majlessi, et al. (2003) Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nature Med 9 533-539.
15. WHO (2006) Global Tuberculosis Control: Surveillance, Planning, Financing Geneva: World Health Organization WHO Report. WHO/HTM/TB/2006.34962.
16. D Van Soolingen (2001) Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Int Med 249 1-26.
17. PM Groenen, D Bunchoten, D van Soolingen, et al. (1993) Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis and its use as an epidemiological tool. Mol Microbiol 10 1057-1065.
18. UNAIDS/Stop TB Partnership (2006) Information pack on TB/HIV Geneva: World Health Organization
19. Y Ahmed, P Mwaba, C Chintu, et al. (1999) A study of maternal mortality at University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Int J Tuberc Lung Dis 3 675-681.
20. WHO (2004) Progress Report on the Global Plan to Stop Tuberculosis Geneva: World Health Organization WHO/HTM/STB/2004.29.
21. WHO (2004) Anti-Tuberculosis Drug Resistance in the World Geneva: World Health Organization Report No. 3. WHO/HTM/2004.343.
22. DA Mitchison (1998) How drug resistance emerges as a result of poor compliance during short course chemotherapy of tuberculosis. Int J Tuberc Lung Dis 2 10-15.
23. Centers for Disease Control (2006) Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR 55 301-305.
24. RPO Davies, K Tocque, MA Bellis, et al. (1999) Historical declines in tuberculosis in England and Wales: improving social conditions or natural selection? Int J Tuberc Lung Dis 3 1051-1054.
25. JM Grange, M Gandy, P Farmer, et al. (2001) Historical declines in tuberculosis - nature, nurture and the biosocial model. Int J Tuberc Lung Dis 3 208-212.
26. V Gajalakshmi, R Peto, TS Kanaka, et al. (2003) Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43 000 adult male deaths and 35000 controls. Lancet 362 507-515.
27. American Thoracic Society and Centers for Disease Control (1994) Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 149 1359-1374.
28. JM Grange, A Ustianowski and A Zumla (1998) Tuberculosis and pregnancy. V Diwan, A Thorson, A Winkvist (Eds) Gender and Tuberculosis Göteborg: Nordic School of Public Health 77-88.
29. CH Collins, JM Grange and MD Yates (1997) Tuberculosis Bacteriology: Organization and Practice 2nd edn. London: Butterworth-Heinemann
30. International Union Against Tuberculosis and Lung Disease (2000) Management of Tuberculosis: A Guide for Low Income Countries 5th edn. Paris: IUATLD
31. HL Rieder, CY Chiang and ID Rusen (2005) A method to determine the utility of the third diagnostic and the second follow-up sputum smear examinations to diagnose tuberculosis cases and failures. Int J Tuberc Lung Dis 9 384-391.
32. MK Leonard, D Osterholt, EV Kourbatova, et al. (2005) How many sputum specimens are necessary to diagnose pulmonary tuberculosis? Am J Infect Control 33 58-61.
33. L Saglam, M Akgun and E Aktas (2005) Usefulness of induced sputum and fibreoptic bronchoscopy specimens in the diagnosis of pulmonary tuberculosis. J Int Med Res 33 260-265.
34. A Olu Osoba (2003) Microbiology of tuberculosis. M Madkour (Eds) Tuberculosis Berlin: Springer 115-132.
35. J Andreu, J Caceres, E Pallisa, et al. (2004) Radiological manifestations of pulmonary tuberculosis. Eur J Radiol 51 139-149.
36. IC Shamputa, L Rigouts and F Portaels (2004) Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens. APMIS 112 728-752.
37. JM Fitzgerald and D Menzies (2003) Interpretation of the tuberculin skin test. PDO Davies (Eds) Clinical Tuberculosis 3rd edn. London: Arnold 323-336.
38. K Dheda, ZF Udwadia, JF Huggett, et al. (2005) Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med 11 195-202.
39. WHO (2006) Guidance for national tuberculosis programmes on the management of tuberculosis in children Geneva: World Health Organization WHO/HTM/TB/2006.371.
40. PB Fourie, PJ Becker, F Festenstein, et al. (1998) Procedures for developing a simple scoring method based on unsophisticated criteria for screening children for tuberculosis. Int J Tuberc Lung Dis 2 116-123.
41. BJ Marais, RP Gie, CC Obihara, et al. (2005) Well defined symptoms are of value in the diagnosis of childhood pulmonary tuberculosis. Arch Dis Child 90 1162-1165.
42. C Delacourt, TM Mani, V Bonnerot, et al. (1993) Computed tomography with normal chest radiograph in tuberculous infection. Arch Dis Child 69 430-432.
43. KC Smith (2002) Congenital tuberculosis: a rare manifestation of a common infection. Curr Opin Infect Dis 15 269-274.
44. BJ Marais, PR Donald, RP Gie, et al. (2005) Diversity of disease in childhood pulmonary tuberculosis. Ann Trop Paediatr 25 79-86.
45. LP Ormerod, M Grundy and MA Rathman (1989) Multiple tuberculous bone lesions resembling metastatic disease. Tubercle 70 305-307.
46. SS Joseffer and PR Cooper (2005) Modern imaging of spinal tuberculosis. J Neurosurg Spine 2 145-150.
47. A Nene and S Bhojraj (2005) Results of nonsurgical treatment of thoracic spinal tuberculosis in adults. Spine J 5 79-84.
48. G Thwaites, TT Chan, NT Mai, et al. (2000) Tuberculous meningitis. J Neurol Neurosurg Psychiatry 68 289-299.
49. IS Johansen, B Lundgren, F Tabak, et al. (2004) Improved sensitivity of nucleic acid amplification for rapid diagnosis of tuberculous meningitis. J Clin Microbiol 42 3036-3040.
50. K Prasad, J Volmink and GR Menon (2000) Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev CD002244.
51. GE Thwaites, DB Nguyen, HD Nguyen, et al. (2004) Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351 1741-1751.
52. HJ Ustvedt (1947) The relationship between renal tuberculosis and primary infection. Tubercle 28 22-25.
53. L Petersen, S Mommsen and G Pallisgaard (1993) Male genitourinary tuberculosis: report of 12 cases and review of the literature. Scand J Urol Nephrol 27 425-428.
54. JB Eastwood, CM Corbishley and JM Grange (2001) Tuberculosis and the kidney. J Am Soc Nephrol 12 1307-1314.
55. JB Eastwood, CM Corbishley, JM Grange (2004) Renal tuberculosis and other mycobacterial infections. AMA Davidson, JS Cameron, J-P Grunfeld, et al., (Eds) Oxford Textbook of Nephrology 4th edn. Oxford: Oxford University Press 7.3.
56. SH Morgan, JB Eastwood and LRI Baker (1991) Tuberculous interstitial nephritis: the tip of an iceberg. Tubercle 71 5-6.
57. JB Eastwood, M Zaidi, JD Maxwell, et al. (1994) Tuberculosis as primary renal diagnosis in end-stage uraemia. J Nephrol 7 290-293.
58. RI Menzies, H Alsen, JM Fitzgerald, et al. (1986) Tuberculous peritonitis in Lesotho. Tubercle 67 47-54.
59. E Tshibwabwa-Tumba, P Mwaba, J Bogle-Taylor, et al. (2000) Four year study of abdominal ultrasound in 900 Central African adults with AIDS referred for diagnostic imaging. Abdominal Imaging 25 290-296.
60. Y Akgun (2005) Intestinal and peritoneal tuberculosis. Changing trends over 10 years and a review of 80 patients. Canadian Journal of Surgery 48 131-136.
61. MJ Falkner, PA Reeve and S Locket (1985) The diagnosis of tuberculous ascites in a rural African community. Tubercle 66 55-59.
62. JM Grange, WC Noble, MD Yates, et al. (1988) Inoculation mycobacterioses. Clin Exp Dermatol 13 211-220.
63. JGL Morrison and ED Fourie (1974) The papulonecrotic tuberculide from Arthus reaction to lupus vulgaris. Br J Dermatol 91 273-277.
64. SK Lau, WI Wei, C Hsu, et al. (1990) Efficacy of fine needle aspiration in the diagnosis of tuberculous cervical lymphadenopathy. J Laryngol Otol 104 24-27.
65. JI Strang (1984) Tuberculous pericarditis in Transkei. Clin Cardiol 7 667-670.
66. WJ Dinning and S Marston (1985) Cutaneous and ocular tuberculosis: a review. J R Soc Med 78 576-581.
67. PH Rosen, DJ Spalton and EM Graham (1990) Intraocular tuberculosis. Eye 4 486-492.
68. EM Alevritis, FA Sarubbi, RM Jordan, et al. (2003) Infectious causes of adrenal insufficiency. South Med J 96 888-890.
69. JR Glynn, AC Crampin, MD Yates, et al. (2005) The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi. J Infect Dis 192 480-487.
70. T Schon, D Wolday, D Elias, et al. (2006) Kinetics of sedimentation rate, viral load and TNF-alpha in relation to HIV co-infection in tuberculosis. Trans R Soc Trop Med Hyg 100 483-488.
71. SB Lucas, CS Peacock, A Hounnou, et al. (1996) Disease in children infected with HIV in Abidjan, Cote-d'Ivoire. BMJ 312 335-338.
72. E Tshibwabwa-Tumba, A Mwinga, JOM Pobee, et al. (1997) Radiological features of pulmonary tuberculosis in 963 HIV-infected adults at three Central African hospitals. Clin Radiol 52 837-841.
73. WHO (2004) TB/HIV. A Clinical Manual 2nd edn. Geneva: World Health Organization
74. SD Lawn, LG Bekker and R Wood (2005) How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS 19 1113-1124.
75. K Grimwade, AW Sturm, AJ Nunn, et al. (2005) Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa. AIDS 19 163-168.
76. WHO HIV/AIDS Programme (2006) Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a public health approach. 2006 Revision Geneva: World Health Organization
77. WHO Global Tuberculosis Programme and UNAIDS (1998) Policy Statement on Preventive Therapy against Tuberculosis in People Living with HIV Geneva: WHO
78. O Cosivi, JM Grange, CJ Daborn, et al. (1998) Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis 4 59-70.
79. RR Kazwala, CJ Daborn, JM Sharp, et al. (2001) Isolation of Mycobacterium bovis from human cases of cervical adenitis in Tanzania: a cause for concern? Int J Tuberc Lung Dis 5 87-91.
80. DA Mitchison (2000) The role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Disease 4 796-806.
81. WHO (2003) Treatment of Tuberculosis: Guidelines for National Programmes 3rd edn. Geneva: WHO WHO/CDS/TB2003.313.
82. P Onyebujoh, A Zumla, I Ribiero, et al. (2005) Treatment of tuberculosis: present status and future prospects. Bull WHO 83 857-865.
83. LE Ziganshina, AA Vizel and SB Squire (2005) Fluoroquinolones for treating tuberculosis. Cochrane Database Syst Rev 3 CD004795.
84. JM Grange and A Zumla (2003) Antituberculosis agents. J Cohen, WG Powderly (Eds) Infectious Diseases 2nd edn. London: Elsevier Health Sciences 1851-1867. Section 7
85. JM Grange (2003) Antimycobacterial agents. RG Finch, D Greenwood, SR Norrby, et al., (Eds) Antibiotic and Chemotherapy 8th edn. Edinburgh: Churchill Livingstone 426-440.
86. CA Peloquin (2003) Clinical pharmacology of antituberculosis drugs. PDO Davies (Eds) Clinical Tuberculosis 3rd edn. London: Arnold 171-190.
87. JL Johnson, RM Kamya, AM Okwera, et al. (2000) Randomised controlled trial of Mycobacterium vaccae immunotherapy in non-immunodeficiency virus-infected Ugandan adults with newly diagnosed pulmonary tuberculosis. J Infect Dis 181 1304-1312.
88. JL Stanford, CA Stanford, JM Grange, et al. (2001) Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for multi-drug-resistant pulmonary tuberculosis? Respir Med 95 444-447.
89. WW Yew (2002) Clinically significant interactions with drugs used in the treatment of tuberculosis. Drug Saf 25 111-133.
90. V Launay-Vacher, H Izzedine and G Deray (2005) Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure. Clin Pharmacokinet 44 221-235.
91. ED Chan, V Laurel, MJ Strand, et al. (2004) Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 169 1103-1109.
92. E Nathanson, C Lambregts-van-Weezenbeek, ML Rich, et al. (2006) Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 12 1389-1397.
93. WHO (2006) Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis Geneva: World Health Organization WHO/HTM/TB/2006.361.
94. P Farmer and JY Kim (1998) Community based approaches to the control of multidrug resistant tuberculosis: introducing ‘DOTS-plus’. BMJ 317 671-674.
95. AH Alzeer and JM FitzGerald (1993) Corticosteroids and tuberculosis: risks and use as adjunct therapy. Tubercle Lung Dis 74 6-11.
96. HL Israel (1993) Chemoprophylaxis for tuberculosis. Respir Med 87 81-83.
97. HM Blumberg, MK Leonard and RM Jasmer (2005) Update on the treatment of tuberculosis and latent tuberculosis infection. J Am Med Assoc 293 2776-2784. (Erratum in J Am Med Assoc 2005; 294:182; dosage error in text).
98. Y Shiraishi, Y Nakajima, N Katsuragi, et al. (2004) Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg 128 523-528.
99. The Winterthur Health Forum (2000) Massive Effort Advocacy Forum Report. Massive Effort Against Diseases of Poverty Geneva: World Health Organization Online. Available: www.winterthurhealthforum.org
100. JM Grange and A Zumla (1999) Tuberculosis and the poverty-disease cycle. J R Soc Med 92 105-107.
101. UN Millennium Project (2005) Investing in Development: A Practical Plan to Achieve the Development Goals New York: UNDP
102. Global Drug Facility (2005) Sustaining the Gains. National Self Sufficiency for TB Drug Access. A Global Drug Facility Strategy Geneva: World Health Organization
103. WHO (2002) An Expanded DOTS Framework for Effective Tuberculosis Control Geneva: World Health Organization
104. Stop TB Partnership and the WHO (2006) The Global Plan to Stop TB: 2006-2015 Geneva: World Health Organization WHO/HTM/STB/2006.35.
105. P Farmer (1997) Social scientists and the new tuberculosis. Soc Sci Med 44 347-358.
106. JA Ogden (1999) Compliance versus adherence: just a matter of language? The politics and poetics of public health. JDH Porter, JM Grange (Eds) Tuberculosis - an Interdisciplinary Perspective London: Imperial College Press 213-234.
107. AMR Chowdhury, SA Chowdhury, MN Islam, et al. (1997) Control of tuberculosis through community health workers in Bangladesh. Lancet 350 160-172.
108. G Williams (2003) Patient holding. PDO Davies (Eds) Clinical Tuberculosis 3rd edn. London: Arnold 427-435.
109. J Volmink and P Garner (2003) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 1 10.1002/14651858.CD003343 CD003343
110. ME Edington, CS Sekante and SJ Goldstein (2002) Patients' beliefs: do they affect tuberculosis control? A study of a rural district of South Africa. Int J Tuberc Lung Dis 6 1075-1082.
111. JM Grange (2005) The stigma of tuberculosis. RJ Pratt, JM Grange, G Williams (Eds) Tuberculosis: A Foundation for Nursing and Healthcare Practice London: Arnold 189-195.
112. P Farmer and JY Kim (1998) Community based approaches to the control of multidrug-resistant tuberculosis: introducing ‘DOTS plus’. BMJ 317 671-674.
113. WHO (2000) Guidelines for Establishing DOTS plus Pilot Projects for the Management of Multi-Drug Resistant Tuberculosis Geneva: World Health Organization
114. UNAIDS (2005) The ‘Three Ones’ in Action: Where we are and Where we go from Here Geneva: UNAIDS
115. PEM Fine (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346 1339-1345.
116. A Lotte, O Wasz-Höckert, N Poisson, et al. (1984) BCG complications. Adv Tuberc Res 21 107-193.
117. WHO (1987) HIV and routine childhood immunization. Wkly Epidemiol Rec 62 297-299.
118. AS Mustafa (2005) Progress towards the development of new anti-tuberculosis vaccines. LT Smithe (Eds) Focus on Tuberculosis Research Hauppauge: Nova Science 47-76.
119. Stop TB Partnership (14 Nov 2005) Global Plan to Stop TB. STOP TB Partnership; 2005. Online. Available: http://www.stoptb.org/gpstb/assets/wgstrategicplans/DEWGfull210905.pdf
120. Scientific Working Group on Tuberculosis (2005) WHO/TDR Report Geneva: World Health Organization TDR/SWG/06.
121. WHO (2005) TB/HIV Research Priorities in Resource-Limited Settings. Scientific working group on Tuberculosis. Report of an expert consultation, 14-15 February Geneva: World Health Organization WHO/HTM/TB/2005.355, WHO/HIV/2005.03.
122. M Perkins, G Rosicgno and A Zumla (2006) Progress towards improved tuberculosis diagnostics in developing countries. Lancet 367 942-943.
123. ST Cole, KD Eisenach, DN McMurray, et al. (Eds) (2004) Tuberculosis and the Tubercle Bacillus Oxford: Blackwell
124. J Crofton, N Horne and F Miller (1999) Clinical Tuberculosis 2nd edn. London: Macmillan
125. PDO Davies (Eds) (2003) Clinical Tuberculosis 3rd edn. London: Arnold
126. PDO Davies and LP Ormerod (1999) Case Presentations in Clinical Tuberculosis London: Arnold
127. PR Donald, PB Fourie and JM Grange (1999) Tuberculosis in Childhood Pretoria: van Schaik
128. M Gandy and A Zumla (2003) Return of the White Plague. Global Poverty and the New Tuberculosis London and New York: Verso Press
129. International Union against Tuberculosis and Lung Disease (2000) Management of Tuberculosis: A Guide for Low Income Countries 5th edn. Paris: IUATLD
130. M Madkour (Eds) (2003) Tuberculosis Berlin: Springer
131. JDH Porter and JM Grange (Eds) (1999) Tuberculosis - an Interdisciplinary Perspective London: Imperial College Press
132. RJ Pratt, JM Grange and G Williams (2005) Tuberculosis: A Foundation for Nursing and Healthcare Practice London: Arnold
133. MC Raviglione (2007) Reichman and Hershfield's Tuberculosis. A Comprehensive, International Approach 3rd edn. New York: Informa care
134. D Schlossberg (2006) Tuberculosis and Nontuberculosis Mycobacterial Infections 5th edn. Maidenhead: McGraw-Hill
135. N Schluger (2005) Tuberculosis. Clinics in Chest Medicine Philadelphia: Saunders